Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
109 studies found for:    PNP
Show Display Options
Rank Status Study
1 Completed
Has Results
Safety Study of Adenovirus/PNP Coupled With Fludarabine Phosphate to Treat Solid Tumors
Condition: Head and Neck Cancer
Intervention: Genetic: Ad/PNP and fludarabine monophosphate
2 Unknown  A Trial to Determine the Maximum Tolerated Dose and Evaluate the Safety and Pharmacokinetics of Docetaxel-PNP, Polymeric Nanoparticle Formulation of Docetaxel, in Subjects With Advanced Solid Malignancies
Condition: Advanced Solid Malignancies
Intervention: Drug: Docetaxel-PNP
3 Active, not recruiting BlueWind Medical Reprieve System for the Treatment of PNP
Condition: Peripheral Neuropathy
Intervention: Device: The Reprieve System
4 Recruiting The Pacing vs No Pacing Study - PNP Study
Condition: Aortic Valve Stenosis
Intervention: Procedure: percutaneous balloon aortic valvuloplasty
5 Not yet recruiting Pharmacokinetic Study of Docetaxel-PNP and Taxotere to Treat Patient With Advanced Solid Cancer
Condition: Solid Tumor
Interventions: Drug: Docetaxel-PNP;   Drug: Taxotere
6 Recruiting Pancreatic Nutritional Program for Weight Loss in Overweight/Obese Patients With Stage I-III Breast Cancer
Conditions: Obesity;   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage IIA Breast Cancer;   Stage IIB Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer
Interventions: Dietary Supplement: Dietary Intervention;   Other: Educational Intervention;   Other: Laboratory Biomarker Analysis;   Other: Quality-of-Life Assessment
7 Unknown  The Effect of Pancreatic Polypeptide on Insulin Requirements for Type 1 & Post-pancreatectomy Diabetic Patients
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Placebo;   Drug: Pancreatic Polypeptide (PP)
8 Completed Study to Evaluate the Pharmacokinetic Properties of SYP-1018 (Voriconazole-loaded PNP) and Voriconazole (Vfend)
Condition: Systemic Mycotic Infection
Interventions: Drug: SYP-1018 200mg;   Drug: Voriconazole 200mg
9 Unknown  N-AcetylCysteine vs. Placebo to Prevent Neurotoxicity Induced by Platinum Containing Chemotherapy
Conditions: Carcinoma, Non-Small-Cell Lung;   Carcinoma, Small Cell Lung;   Mesothelioma
Interventions: Drug: N-Acetylcysteine;   Drug: Placebo
10 Recruiting The Effect of a Cash Transfer Program on Household Welfare and Child Nutritional Status in Mali
Conditions: Poverty;   Child Malnutrition
Interventions: Other: Cash distribution during 36 months;   Behavioral: Accompanying information sessions on health, child nutrition, household economics and education during 36 months;   Dietary Supplement: PNP;   Other: Cash distribution during the last 12 months;   Behavioral: Accompanying information sessions on health, child nutrition, household economics and education during the last 12 months
11 Recruiting BlueWind Reprieve System for the Treatment of PNP
Condition: Peripheral Neuropathic Pain
Intervention: Device: The Reprieve system
12 Completed
Has Results
Purge Vs no Purge in Living Donor Liver Transplantation Recipients
Condition: Ischemia Reperfusion Injury
Intervention: Other: Purge of graft contents out of the circulation
13 Recruiting Arterial and Plethysmographic Waveforms Variables as Predictors of Hemodynamic Response to Pneumoperitoneum
Conditions: Pneumoperitoneum;   Heart Output Disorder
Intervention: Procedure: Pneumoperitoneum
14 Completed A Study to Compare QUTENZA With Pregabalin for the Treatment of Peripheral Neuropathic Pain (PNP) After 8 Weeks of Treatment
Conditions: Postherpetic Neuralgia (PHN);   Peripheral Nerve Injury (PNI);   Non-diabetic Painful Peripheral Polyneuropathy
Interventions: Drug: Qutenza;   Drug: Pregabalin
15 Unknown  Safety and Feasibility Study of Autologous Progenitor Cell Transplantation in Diabetic Neuropathy
Condition: Diabetic Neuropathies
Intervention: Procedure: Intraarterial bone marrow progenitor cell transplantation
16 Completed Method of Pre-treatment for Application of QUTENZA Capsaicin 8% Patch
Conditions: Peripheral Neuropathic Pain (PNP) Due to Postherpetic Neuralgia (PHN);   or Peripheral Nerve Injury (PNI)
Interventions: Drug: QUTENZA;   Drug: Lidocaine;   Drug: Tramadol
17 Completed Cosmetic Outcomes and Patient Satisfaction After Facial Laceration Repair in the Emergency Department
Condition: Facial Lacerations
18 Terminated Safety, Tolerability and Efficacy Study of PP1420 in HV
Condition: Obesity
Interventions: Drug: PP1420;   Drug: Placebo
19 Completed
Has Results
ZOSTAVAX™ Administered Concomitantly With PNEUMOVAX™ 23 (V211-012)(COMPLETED)
Conditions: Herpes Zoster;   Pneumococcal Infection
Interventions: Biological: Zoster Vaccine, Live, (Oka-Merck), ZOSTAVAX™;   Biological: Comparator: placebo (concomitant-vaccine matched);   Biological: Pneumococcal Vaccine, Polyvalent (23-valent), PNEUMOVAX™ 23
20 Completed Effect of Alcohol on Cephalic Phase Reflex and Gene Expression
Conditions: Type 2 Diabetes;   Inflammation;   Carbohydrate&Lipid Metabolism;   Oral Processing
Interventions: Dietary Supplement: alcohol;   Dietary Supplement: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years